A virtual Experts Knowledge Share on the topic ‘New oral endocrine therapy options in breast cancer’ chaired by Dr Sara Tolaney (US) and co-chaired by Dr Aditya Bardia (US) and Prof. Frederique Penault-Llorca (France).

Learn about and discuss:

1. Oral SERDs efficacy and safety profiles in patients with ER+/HER2- advanced or metastatic breast cancer and their place in treatment landscape 
2. How to optimize treatment selection and sequencing in ER+/HER2- advanced or metastatic breast cancer
3. Why, when and how to test for ESR1 mutation in patients with ER+/HER2- advanced or metastatic breast cancer

This event is in collaboration with BREAST CANCER CONNECT, a group of international experts in breast cancer. 

You will also have the opportunity to contribute to the discussion on this important topic. If you would like to submit a question for the Scientific Committee, please send them to selina.gill@cor2ed.com